Evidence map›Paper›PMID 27554090›Full record

ArticleAdvances in therapy2016

Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Dimitrios Baltzis, Matthieu Roustit, Maria G Grammatikopoulou, Dimitrios Katsaboukas, Vassileios Athanasiou, Ioannis Iakovou, Aristidis Veves, Christos Manes, Maria-Christina Trakatelli

Open access · hybridAbstract read
In one paragraph

Article in Advances in therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Dimitrios BaltzisMicrocirculation Lab, Joslin-Beth Israel Deaconess Foot Center and Rongxiang Xu, MD, Center for Regenerative Therapeutics, Harvard Medical School, Boston, MA, USA. dbaltzis@bidmc.harvard.edu.
Matthieu RoustitMicrocirculation Lab, Joslin-Beth Israel Deaconess Foot Center and Rongxiang Xu, MD, Center for Regenerative Therapeutics, Harvard Medical School, Boston, MA, USA.
Maria G GrammatikopoulouDepartment of Nutrition and Dietetics, Alexander Technological Educational Institute, Thessaloniki, Greece.
Dimitrios KatsaboukasThird Department of Nuclear Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Vassileios AthanasiouThird Department of Nuclear Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Ioannis IakovouThird Department of Nuclear Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Aristidis VevesMicrocirculation Lab, Joslin-Beth Israel Deaconess Foot Center and Rongxiang Xu, MD, Center for Regenerative Therapeutics, Harvard Medical School, Boston, MA, USA.
Christos ManesDiabetes Center, Papageorgiou General Hospital, Thessaloniki, Greece.
Maria-Christina TrakatelliThird Department of Internal Medicine, Papageorgiou General Hospital, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRBeth Israel Deaconess Medical Center · USPapageorgiou General Hospital · GRAlexander Technological Educational Institute of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes and has been associated with cardiovascular disease, the leading cause of mortality in diabetes. As asymptomatic myocardial ischemia (MI) is frequent in diabetes, we hypothesized that DPN may be associated with MI in patients with type 2 diabetes mellitus and no history of cardiovascular events.

methodsEighty-two patients with DPN (n = 41) or without DPN (n = 41) were included. Among the DPN group, 15 had active foot ulcers. All subjects underwent Technetium-99 m sestamibi single-photon emission computed tomographic imaging for the estimation of myocardial ischemia, expressed as Summed Stress Score (SSS). The Neuropathy Disability Score (NDS) was used to quantify DPN and abnormal ratio of the longest electrocardiographic RR interval between the 28th and 32nd beats, after standing to the shortest interval between the 13th and 17th beats (RR ratio) was used as an index of cardiovascular autonomic neuropathy (CAN).

resultsAbnormal SSS was observed in 9.8% of patients without DPN and in 46.3% of patients with DPN (p < 0.001). In the multivariate analysis, NDS was the strongest predictor for SSS (β = 0.32, p = 0.003). When excluding patients with abnormal RR ratio (β = 0.32, p = 0.003) or with foot ulcers (β = 0.24, p = 0.04), this association remained significant. The RR ratio was also significantly associated with SSS in univariate (ρ = -0.30, p = 0.005) and multiple regressions (β = 0.24, p = 0.02).

conclusionsMI was strongly associated with DPN, and this association remained significant in patients with normal RR ratio. These results suggest that DPN assessment could help in identifying patients at risk of cardiovascular disease (CVD).

Indexed as

Myocardial IschemiaAgedAsymptomatic DiseasesCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic NeuropathiesDisability EvaluationElectrocardiographyFemaleGreeceHumansMaleMiddle AgedPeripheral Nervous System DiseasesStatistics as TopicTomography, Emission-Computed, Single-PhotonCardiovascular autonomic neuropathyDiabetesDiabetic foot ulcerDiabetic peripheral neuropathyMyocardial ischemiaType 2 diabetes mellitus

Identifiers

PMID27554090
PMCPMC5055555
OpenAlexW2513589184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.